Preliminary results of surufatinib (Suru) plus standard chemotherapy (ChT) as second line (2L) treatment of advanced gastric cancer (aGC): A single-arm, phase 2 clinical trial.
In: Journal of Clinical Oncology, Jg. 42 (2024-01-23), S. 353-537
Online
academicJournal
Zugriff:
Titel: |
Preliminary results of surufatinib (Suru) plus standard chemotherapy (ChT) as second line (2L) treatment of advanced gastric cancer (aGC): A single-arm, phase 2 clinical trial.
|
---|---|
Autor/in / Beteiligte Person: | Han, Ting ; Lin, Xiaolin ; Zhuo, Meng ; Jiao, Feng ; Cui, Jiujie ; Qiu, Xiaoxia ; Xiao, Xiuying |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 42 (2024-01-23), S. 353-537 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 0732-183X (print) |
DOI: | 10.1200/JCO.2024.42.3_suppl.353 |
Sonstiges: |
|